Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Becatecarin in Metastatic Colorectal Cancer
NCT00005085Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Feb 2000
- Primary completion
- Jun 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of becatecarin in colorectal cancer (CRC), sponsored by National Cancer Institute. Started Feb 2000; status: completed.
02
Drugs
becatecarin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00005085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005085.